Within  days of registration: Serum calcium =< . mg/dL
Serum calcium > mg/dL
Documented within  days of registration: Calcium: >=  mg/dL
Serum calcium > . and < . mg/dL
Primary hyperparathyroidism (serum calcium [Ca] > . mg/dL and parathyroid hormone (PTH) >  pg/ml)
Calcium (Ca) < . mg/dl
Corrected serum calcium >=  mg/dl within  weeks of enrollment (despite appropriate measure such a short course of steroids, bisphosphonates, hydration, and calcitonin)
Serum calcium =< . mg/dL
Serum calcium or albumin-adjusted serum calcium >= . mmol/L (. mg/dL) and =< . mmol/L (. mg/dL)
Patients must have a serum calcium of >= . mmol/L (. mg/dL) or albumin-adjusted serum calcium =< . mmol/L (. mg/dL) within  days of registration; (Note: if patients are undergoing treatment for hypocalcemia and the serum calcium value at screening is > . mg/dl, then the patient will be eligible for this study)
Serum calcium or albumin-adjusted serum calcium >= . mmol/L (. mg/dL) and =< . mmol/L (. mg/dL)
Serum calcium =< . mg/dL
Serum calcium =<  mg/dl within  days of study entry
Serum calcium < .mg/dL
Uncontrolled hypercalcemia (defined as serum calcium >  mg/dL)
Serum calcium or albumin-adjusted serum calcium >= . mmol/L (. mg/dL) and =< . mmol/L (. mg/dL) (reference range .-. mg/dL)
Uncontrolled symptomatic hypercalcemia (> . mmol/L ionized calcium or calcium >  mg/dl or corrected serum calcium > ULN)
Patient has symptomatic MM, as defined by any of the following:\r\n* Lytic lesions or pathologic fractures\r\n* Anemia (hemoglobin <  g/dL)\r\n* Hypercalcemia (corrected serum calcium > . mg/dL)\r\n* Renal insufficiency (creatinine > . mg/dL)\r\n* Other: symptomatic hyperviscosity, amyloidosis
Baseline serum calcium < . mg/dL (calcium supplementation may be given to restore the serum calcium above this level prior to study entry)
Screening serum calcium levels < . mmol/L [. mg/dL] (after correction for serum\n             albumin
Hypercalcemia, defined as a calcium of >  mg/dL
(C) Calcium elevation (serum calcium >. mg/dl )(> . mmol/L)
Corrected serum calcium >. mg/dL (> . mmol/L)
Corrected serum calcium superior to  mg per dL (superior to . mmol per L).
Absence of hypercalcemia attributed to the plasma cell disorder*: calcium (Ca) < . mg/dl or =< . mmol/L\r\n* To be determined based on clinical and laboratory assessment by the primary oncologist
Serum calcium =< . mg/dL
Serum calcium or albumin-adjusted serum calcium >= . mmol/L (. mg/dL) and =< . mmol/L (. mg/dL)
Hypercalcemia: serum calcium > . mmol/L (>  mg/dL) higher than the upper limit of normal or > . mmol/L (>  mg/dL)
Serum calcium =< . mg/dL
Serum calcium =< . mg/dL
Patients with hypercalcemia (blood levels greater than . mg/dL) and/or abnormally high vitamin D levels (in patients with kidney disease, blood calcium levels must be . mg/dL or lower before starting paricalcitol)
Serum calcium or albumin-adjusted serum calcium >= . mmol/L (. mg/dL) and =< . mmol/L (. mg/dL)
Patient must have a calcium phosphate product (CPP) =< . mmol^/L^ or  mg^/dL^
Serum calcium =< . mg/dL
Serum calcium =< . mg/dL
Serum calcium =< . mg/dL
For Cohort C only: Subjects must have a calcium phosphate product (CPP) of <. mmol^/L^ ( mg^/dL^) if they are to continue treatment with GSK
Serum calcium or albumin-adjusted serum calcium ? . mmol/L (. mg/dL) and ? . mmol/L (. mg/dL)
Serum calcium =< . mg/dL
Serum calcium below the CTCAE grade  upper limit (. mg/dL or . mmol/L); in cases where the serum calcium is below the normal range, the calcium adjusted for albumin is calculated and substituted for the measured value
Myeloma-related organ dysfunction (at least one of the following) [C] Calcium elevation in the blood (serum calcium >. mg/dl or upper limit of normal) [R] Renal insufficiency (serum creatinine > mg/dl) [A] Anemia (hemoglobin < g/dl or  g < laboratory normal) [B] Lytic bone lesions or osteoporosis AND have measurable disease by protein electrophoresis analyses as defined by the following:
Patients with a calcium level greater than mg/dL.
Preoperative serum calcium levels >= . mg/dL
Serum calcium <. mg/dL
Serum calcium or albumin-adjusted serum calcium . mmol/L (. mg/dL) and . mmol/L (. mg/dL)
Serum calcium or albumin adjusted >= . mg/dL and =< . mg/dL
Hypocalcemia (serum calcium or albumin adjusted calcium < . mg/dL) or renal dysfunction (creatinine clearance <  mL/min)
Serum calcium <  mg/dL, obtained =<  days prior to registration; note: patients with hypercalcemia can be enrolled after the calcium is corrected with standard of care treatments
Hypo- (calcium [Ca] < . mg/dL) or hyper-calcemia (Ca > . mg/dL)
Serum calcium >  mg/dL
Calcium >  mg/dL
